Evidence map›Paper›PMID 33430873›Full record

ReviewCell communication and signaling : CCS2021

Effects of therapeutic probiotics on modulation of microRNAs.

Amirhossein Davoodvandi, Havva Marzban, Pouya Goleij, Amirhossein Sahebkar, Korosh Morshedi, Samaneh Rezaei, Maryam Mahjoubin-Tehran, Hossein Tarrahimofrad, Michael R Hamblin, Hamed Mirzaei

Open access · goldAbstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Lactobacilli and gut pH: features of correlation in model experiments.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Exosomes and microRNAs as mediators of the exercise.European journal of medical research · 2025
    Review
  13. Review
  14. The Beneficial Effects ofInternational journal of molecular sciences · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Novel Probiotic BacteriumMicroorganisms · 2023
    Article
  20. Neuroprotective Effects ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Amirhossein DavoodvandiStudent Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
Havva MarzbanDepartment of Veterinary Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Pouya GoleijDepartment of Genetics, Faculty of Biology,Sana Institute of Higher Education, Sari, Iran.
Amirhossein SahebkarBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Korosh MorshediFaculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Samaneh RezaeiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Maryam Mahjoubin-TehranStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Hossein TarrahimofradDepartment of Animal Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Michael R HamblinWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, Boston, MA, 02114, USA. HAMBLIN1@helix.mgh.harvard.edu.
Hamed MirzaeiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran. mirzaei-h@kaums.ac.ir.
Kashan University of Medical Sciences · IRMashhad University of Medical Sciences · IRBiotechnology Research Center · IRHarvard University · USNational Institute of Genetic Engineering and Biotechnology · IRUniversity of Tehran · IR

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract InfectionsR21AI121700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2016 to 2017
$462k
NIAID NIH HHS R01 AI050875NIAID NIH HHS R21 AI121700
6 · The paper itself

Abstract

Probiotics are beneficial bacteria that exist within the human gut, and which are also present in different food products and supplements. They have been investigated for some decades, due to their potential beneficial impact on human health. Probiotics compete with pathogenic microorganisms for adhesion sites within the gut, to antagonize them or to regulate the host immune response resulting in preventive and therapeutic effects. Therefore, dysbiosis, defined as an impairment in the gut microbiota, could play a role in various pathological conditions, such as lactose intolerance, gastrointestinal and urogenital infections, various cancers, cystic fibrosis, allergies, inflammatory bowel disease, and can also be caused by antibiotic side effects. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate gene expression in a post-transcriptional manner. miRNAs are biochemical biomarkers that play an important role in almost all cellular signaling pathways in many healthy and disease states. For the first time, the present review summarizes current evidence suggesting that the beneficial properties of probiotics could be explained based on the pivotal role of miRNAs. Video Abstract.

Indexed as

MicroRNAsAnimalsHumansProbioticsMicroRNAsBiomarkersCancerInflammatory bowel diseaseMicroRNAsProbioticsSupplements

Identifiers

PMID33430873
PMCPMC7798223
OpenAlexW3119860522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.